Similar articles

• Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. I. The effect of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in normal rats.

  Tomita T, Takeshita R, Nagakura T, Hayashi E. Tomita T, et al. Jpn J Pharmacol. 1973 Jun;23(3):281-7. doi: 10.1254/jjp.23.281. Jpn J Pharmacol. 1973. PMID: 4541943 No abstract available.
• Effect of the ethyl ester and sodium salt of alpha-p-chlorophenoxyisobutyric acid on cholesterol oxidation by rat liver mitochondria.

  Kritchevsky D, Tepper SA, Sallata P, Kabakjian JR, Cristofalo VJ. Kritchevsky D, et al. Proc Soc Exp Biol Med. 1969 Oct;132(1):79-82. Proc Soc Exp Biol Med. 1969. PMID: 5344871 No abstract available.
• The hypolipidemic effect of SU-13,437 in rats with natural endogenous hypertriglyceridemia.

  Lenz PH, Fleischman AI. Lenz PH, et al. Lipids. 1971 Nov;6(11):783-6. doi: 10.1007/BF02531205. Lipids. 1971. PMID: 5127473 No abstract available.
• Effect of clofibrate and 1-methyl-4-piperidyl bis (p-chlorophenoxy) acetate (Sandox 42-348) on steroid and drug metabolism by rat liver microsomes.

  Salvador RA, Haber S, Atkins C, Gommi BW, Welch RM. Salvador RA, et al. Life Sci. 1970 Apr 8;9(7):397-407. doi: 10.1016/0024-3205(70)90242-0. Life Sci. 1970. PMID: 5445848 No abstract available.
• Pharmacological modification of lipoprotein(a).

  Suckling K. Suckling K. Biochem Soc Trans. 1999 Aug;27(4):466-9. doi: 10.1042/bst0270466. Biochem Soc Trans. 1999. PMID: 10917622 Review. No abstract available.